This is unpublished
ATRIA-CKD
Active Studies
CKD
Pinned
Principal Investigator
Nisha Bansal
Funding Agency
NHLBI
Status
Active
Investigator
What is the ATRIA-CKD Study?
This study uses “real world” data to study the efficacy and safety of atrial fibrillation therapies in patients with chronic kidney disease. This study is evaluating ~250,000 patients with incident atrial fibrillation, with and without CKD.
What are the goals of the study?
To evaluate the adverse effects of commonly used atrial fibrillation therapies and procedures. Further, the study will evaluate whether the successful use of atrial fibrillation therapies and procedures reduces rates of stroke, progression of kidney disease, heart failure, and death.